1.Micha, R & Mozaffarian, D (2008) Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids 79, 147–152.
2.Teegala, SM, Willett, WC & Mozaffarian, D (2009) Consumption and health effects of trans fatty acids: a review. J AOAC Int 92, 1250–1257.
3.Mozaffarian, D & Clarke, R (2009) Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63, Suppl. 2, S22–S33.
4.Uauy, R, Aro, A, Clarke, Ret al. (2009) WHO Scientific update on trans fatty acids: summary and conclusions. Eur J Clin Nutr 63, Suppl. 2, S68–S75.
6.Ghafoorunissa, G (2008) Role of trans fatty acids in health and challenges to their reduction in Indian foods. Asia Pac J Clin Nutr 17, 212–215.
7.Butt, MS & Sultan, MT (2009) Levels of trans fats in diets consumed in developing economies. J AOAC Int 92, 1277–1283.
8.Agrawal, A, Gupta, R, Varma, Ket al. (2008) High trans fatty acid content in common Indian fast foods. Nutr Food Sci 38, 564–569.
9.Perez-Ferrer, C, Lock, K & Rivera, JA (2010) Learning from international policies on trans fatty acids to reduce cardiovascular disease in low- and middle-income countries, using Mexico as a case study. Health Policy Plan 25, 39–49.
10.Bysted, A, Mikkelsen, AA & Leth, T (2009) Substitution of trans fatty acids in foods on the Danish market. Eur J Lipid Sci Technol 111, 574–583.
11.Astrup, A (2006) The trans fatty acid story in Denmark. Atheroscler Suppl 7, 43–46.
12.Leth, T, Jensen, HG, Mikkelsen, AAEet al. (2006) The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl 7, 53–56.
13.Coombes, R (2011) Trans fats: chasing a global ban. BMJ 343, d5567.
14.L'Abbé, MR, Stender, S, Skeaff, Met al. (2009) Approaches to removing trans fats from the food supply in industrialized and developing countries. Eur J Clin Nutr 63, Suppl. 2, S50–S67.
16.Angell, SY, Silver, LD, Goldstein, GPet al. (2009) Cholesterol control beyond the clinic: New York City's trans fat restriction. Ann Intern Med 15, 129–134.
17.Angell, SY, Cobb, LK, Curtis, CJet al. (2012) Change in trans fatty acid content of fast-food purchases associated with New York City's Restaurant Regulation: a pre–post study. Ann Intern Med 157, 81–86.
18.Bell, E (2010) Research For Health Policy. New York: Oxford University Press.
19.Bertaux, D (editor) (1981) From the life-history approach to the transformation of sociological practice. In Biography and Society: The Life History Approach in the Social Sciences, p. 37. Beverly Hills, CA: SAGE Publications.
20.Quine, S (1998) Sampling in non-numerical research. In Handbook of Public Health Methods, pp. 539–542 [C Kerr, R Tayor and G Heard, editors]. Sydney: McGraw-Hill.
21.Yin, RK (2009) Case Study Research: Design and Methods, 4th ed. Thousand Oaks, CA: SAGE Publications.
22.Grbich, C (1999) Qualitative Research in Health. Sydney: Allen & Unwin.
23.Robson, C (2002) Real World Research. Malden: Blackwell Publishing.
24.Walt, G & Gilson, L (1994) Reforming the health sector in developing-countries – the central role of policy analysis. Health Policy Plan 9, 353–370.
26.Colon-Ramos, U, Lindsay, AC, Monge-Rojas, Ret al. (2007) Translating research into action: a case study on trans fatty acid research and nutrition policy in Costa Rica. Health Policy Plan 22, 363–374.
27.Walt, G, Shiffman, J, Schneider, Het al. (2008) ‘Doing’ health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan 23, 308–317.
28.Mozaffarian, D (2010) Removing industrial trans fat from foods. BMJ 340, 1094–1095.
29.Eckel, RH, Kris-Etherton, P, Lichtenstein, AHet al. (2009) Americans’ awareness, knowledge, and behaviors regarding fats: 2006–2007. J Am Diet Assoc 109, 288–296.
30.Vesper, H, Kuiper, H, Mirel, Let al. (2012) Levels of plasma trans-fatty acids in non-Hispanic White adults in the United States in 2000 and 2009. JAMA 307, 562–563.
32.McColl, K (2008) New York's road to health. BMJ 337, a673.
33.Hawkes, C & Buse, K (2011) Public–private engagement for diet and health: addressing the governance gap. SCN News issue 39, 6–10.
34.Katan, MB (2006) Regulation of trans fats: the gap, the Polder, and McDonald's French fries. Atheroscler Suppl 7, 63–66.
35.Mello, M (2009) New York City's war on fat. N Engl J Med 360, 2015–2020.
36.Vogel, L (2010) Public health and nutrition advocates fear regulatory inaction has become the norm. CMAJ 182, E465–E466.
37.Ricciuto, L, Lin, K & Tarasuk, V (2009) A comparison of the fat composition and prices of margarines between 2002 and 2006, when new Canadian labelling regulations came into effect. Public Health Nutr 12, 1270–1275.
38.Ratnayake, WMN, L'Abbe, MR, Farnworth, Set al. (2009) Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population. J AOAC Int 92, 1258–1276.
39.Monge-Rojas, R, Colon-Ramos, U, Jacoby, Eet al. (2011) Voluntary reduction of trans-fatty acids in Latin America and the Caribbean: current situation. Rev Panam Salud Publica 29, 126–129.
40.Nielsen, K (2006) Is the quality and cost of food affected if industrially produced trans fatty acids are removed? Atheroscler Suppl 7, 61–62.
41.Tarrago-Trani, MT, Phillips, KM, Lemar, LEet al. (2006) New and existing oils and fats used in products with reduced trans-fatty acid content. J Am Diet Assoc 106, 867–880.
42.Farmani, J, Safari, M & Hamedi, M (2006) Application of palm olein in the production of zero-trans Iranian vanaspati through enzymatic interesterification. Eur J Lipid Sci Technol 108, 636–643.
43.Skeaff, CM (2009) Feasibility of recommending certain replacement or alternative fats. Eur J Clin Nutr 63, Suppl. 2, S34–S49.
45.Gerberding, JL (2009) Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake. Ann Intern Med 21, 137–138.
46.Redelings, MD, Piron, J, Smith, LVet al. (2010) Readiness and perceived barriers to removing artificial trans-fat from restaurant menus. J Public Health Policy 31, 119–127.